Monday, July 27, 2026

< + > The Hidden Risk of Rushed Technology: Patrick Lo on Establishing AI Governance

The healthcare industry is rushing to adopt artificial intelligence tools, but many organizations are moving too fast without proper safeguards. Deploying automated systems without a clear plan for risk management can expose a health system to major compliance liabilities and operational failures.

Healthcare IT Today sat down with Patrick Lo, CEO of Privacy Horizon, at the eHealth26 conference to discuss why healthcare organizations must establish solid AI governance before deploying new digital health solutions.

Core Insight: Trust Before Intelligence

Healthcare organizations must establish comprehensive AI governance, including cross-functional risk management frameworks and clear lines of accountability, before deploying any automated clinical or administrative tools.

The Necessity of Pre-Deployment Controls

Healthcare leaders rush into vendor contracts without evaluating the long-term operational impacts on their staff. Patrick warns that organizations must prepare their compliance infrastructure well before any software integration goes live. “You just cannot just deploy a solution and hope for the best without thinking about what should prepare and put in place before you adopt a solution,” Lo explained.

Establishing Committee Accountability

Effective governance means bringing different stakeholders to the table to validate the operational purpose and risk profile of a new tool. Committees must assign clear ownership to handle system errors and manage vulnerabilities before technology enters the clinical environment.

“Before you deploy anything that’s AI, you should have an AI governance, which means including how do you make decision to deploy an AI? Why do you need to deploy an AI? Who should be accountable?” Lo noted.

Questions Healthcare IT Leaders are Asking

Why is AI governance required before a technology deployment? AI governance establishes critical rules for decision-making and risk management prior to software integration. Without this foundation, healthcare facilities risk implementing tools that compromise patient privacy or lack clear lines of staff accountability when automated errors occur.

What primary questions should an AI governance committee address? A cross-functional committee must explicitly define the clinical or administrative problem the technology is intended to solve. Leaders must also determine who is operationally accountable for the data inputs, system outputs, and ongoing risk mitigation frameworks.

Learn more about Privacy Horizon at https://www.privacyhorizon.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.



< + > Healthcare AI Advances with Precision and Data Control

The following is a guest article by Paul Speciale, Chief Technology Evangelist and CMO at Scality

Artificial intelligence adoption is accelerating across nearly every industry, but healthcare and life sciences organizations are approaching the technology differently than many of their peers. While sectors such as financial services and manufacturing are rapidly expanding the use of generative AI and edge-based systems, healthcare organizations are prioritizing precision, governance, and data control as they scale AI into production.

That measured approach reflects the realities of the healthcare environment. Clinical and operational AI systems must deliver reliable outcomes, operate within strict regulatory frameworks, and protect highly sensitive patient data. As a result, healthcare organizations are favoring proven and explainable AI models while building infrastructure strategies designed to support long-term operational resilience.

New research from Freeform Dynamics, based on a survey of 504 enterprises actively running private AI environments, highlights how healthcare organizations are balancing innovation with risk management as AI adoption matures. 

Healthcare Favors Established AI Approaches

The survey reveals that healthcare and life sciences organizations continue to invest heavily in established AI technologies. Traditional machine learning leads adoption at 52%, while computer vision and image processing workloads account for 50% of deployments. Fine-tuned or customized AI models are also gaining traction at 44%. 

These numbers reflect the practical realities of healthcare AI. Machine learning models have long been used to support operational analytics, patient risk scoring, and predictive workflows. Meanwhile, computer vision is already deeply embedded in diagnostic imaging, pathology analysis, and radiology applications.

The report specifically notes that healthcare organizations show “notably lower LLM adoption,” likely due to concerns about “variability of output, hallucinations and regulatory constraints.” That caution is reflected in the survey data, with only 31% of healthcare organizations reporting adoption of RAG-enhanced foundation LLMs, well below financial services at 67% and manufacturing at 57%. 

This gap does not suggest healthcare is falling behind in AI adoption. Instead, it highlights a more selective and risk-aware deployment strategy. Healthcare organizations are focusing AI investments on areas where outcomes can be validated, monitored, and governed effectively.

AI in Healthcare is Expanding Beyond Pilots

Although healthcare organizations are moving cautiously with newer AI approaches, the survey makes clear that AI adoption overall is broadening rapidly across enterprises.

Among all respondents:

  • 68% are active with at least three different AI genres 
  • 29% are active with at least five AI categories 
  • 54% report having an overall AI strategy 
  • 49% say AI initiatives are generally well funded 

Healthcare organizations are participating in this broader evolution, particularly as AI use cases expand beyond isolated pilot projects into operational environments.

The report emphasizes that enterprises increasingly view AI as a strategic initiative tied to competitive differentiation, operational efficiency, and customer expectations. In healthcare, this can translate into faster diagnostics, improved clinical workflows, better resource utilization, and more personalized patient experiences.

At the same time, healthcare organizations face a uniquely high burden of responsibility around data governance, explainability, and compliance. This creates additional pressure to ensure AI systems are tightly aligned with organizational controls and infrastructure policies.

Private AI Gains Momentum in Healthcare

One of the strongest themes emerging from the research is the growing importance of private AI infrastructure, also referred to as sovereign AI.

Across all industries surveyed, 81% of organizations say private AI infrastructure they control is critical to their success. The report attributes this trend to concerns around sovereignty, compliance, data proximity, performance, and long-term cost management. 

These priorities are especially relevant in healthcare environments, where organizations must maintain strict oversight of patient records, imaging data, genomic datasets, and other highly regulated information.

Rather than relying entirely on public cloud AI services, many healthcare organizations are adopting hybrid or private AI architectures that allow them to keep data closer to clinical systems and internal governance controls.

The report notes that private AI can also reduce latency and improve throughput by keeping AI applications close to the data they rely on. For healthcare organizations handling large diagnostic images, real-time monitoring systems, or longitudinal patient records, these performance advantages can be significant.

Data Infrastructure is Becoming the Real AI Battleground

While public discussion around AI often centers on GPUs and compute power, the Freeform Dynamics research suggests enterprises increasingly recognize storage and data infrastructure as equally critical. The study found that:

  • 57% of organizations prioritize storage performance to avoid AI bottlenecks 
  • 54% prioritize compute and GPU availability 
  • 52% focus on network bandwidth limitations 

In addition, 86% of respondents recognize that different stages of the AI pipeline require different storage approaches. 

For healthcare organizations, this is particularly important because AI workloads often span multiple data-intensive stages, from data preparation and cleansing to model training and runtime inference. These environments must also support long-term data storage and retention requirements while maintaining compliance, governance, and audit management across the entire AI lifecycle.

Healthcare environments also generate enormous volumes of unstructured data, including imaging files, clinical notes, research datasets, and telemetry streams from connected devices. Managing these diverse datasets efficiently requires infrastructure that can scale while maintaining strong security and resilience. 

The report further found that 91% of organizations running private AI environments rely meaningfully on object storage, with 44% using it extensively. Object storage is increasingly becoming foundational for AI pipelines because it supports scalability, lifecycle management, and the handling of massive data repositories.

Security and Resilience Remain Central Concerns

Healthcare’s cautious AI adoption strategy is also shaped by cybersecurity and operational resilience requirements. The survey found that enterprises place cybersecurity, operational resilience, regulatory compliance, and sovereignty among the most important factors influencing AI storage decisions. 

Respondents also identified concerns around data leakage and unauthorized access, ransomware attacks targeting AI pipeline data, data corruption and integrity issues, and the ability to recover systems and data quickly following an incident. These concerns are amplified in healthcare, where AI failures or compromised data can directly affect patient outcomes and increase regulatory and compliance exposure.

Healthcare organizations must also navigate stringent data privacy and governance requirements, including HIPAA regulations in the United States and GDPR requirements across Europe. As AI initiatives expand across clinical, operational, and research environments, organizations are under increasing pressure to ensure sensitive patient and healthcare data remains secure, auditable, and properly governed throughout the AI lifecycle.

As a result, healthcare organizations are increasingly recognizing that AI infrastructure decisions cannot focus solely on performance. Security, recoverability, and governance must be integrated across the entire AI lifecycle. 

Healthcare’s AI Future will be Data-Centric

The research suggests healthcare organizations are not resisting AI adoption. Instead, they are building toward a more deliberate and sustainable model for operational AI.

Compared with industries such as manufacturing and financial services, healthcare may appear more conservative in adopting large language models and distributed AI systems. However, healthcare’s emphasis on explainability, governance, and trusted data pipelines may ultimately position the sector for more sustainable long-term AI deployment.

The report concludes that organizations with more AI experience tend to adopt more strategic infrastructure planning approaches, prioritize versatile platforms over siloed point solutions, and define storage requirements earlier in the deployment lifecycle. 

For healthcare organizations, these lessons are especially relevant. As AI adoption expands across diagnostics, operations, research, and patient engagement, success will increasingly depend on the ability to operationalize AI securely and at scale. The next phase of healthcare AI will likely be defined less by headline-grabbing models and more by the underlying data infrastructure that enables trusted, resilient, and compliant AI systems.

About Paul Speciale

Paul Speciale is a data storage and cloud industry veteran with over 20 years of experience with small and large companies. Paul is currently the Chief Technology Evangelist and CMO for Scality, leading the team across activities ranging from building awareness to content development and lead generation, as well as being a spokesperson for the company.



< + > CARPL.ai Raises $10M Led by IFC | Pearl Health Raises $110 Million

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.


CARPL.ai Raises $10M Led by IFC to Accelerate Healthcare AI Adoption Globally

CARPL.ai, the world’s largest radiology AI marketplace and enterprise platform, today announced a Series A round of USD $10 million led by International Finance Corporation (IFC), the private sector arm of the World Bank Group, with participation from Stellaris Venture Partners and other investors. The funding will accelerate CARPL’s mission to help healthcare providers adopt AI in a meaningful and safe manner.

CARPL is trusted by the world’s largest and most prestigious healthcare organizations, including four of the world’s top five private radiology groups. It is also being used by many governments, including Brazil, India, Singapore, Spain and the UAE.

Medical imaging generates more than 80% of healthcare data, as imaging demand continues to outpace radiologist capacity. Although more than 1,000 FDA-cleared radiology AI applications are available today, adoption remains fragmented. Healthcare organizations are forced to evaluate, integrate, and monitor dozens of standalone AI products independently, creating significant operational and IT complexity. In short, while the AI applications exist, the governance of these applications does not.

Through a single integration with CARPL, healthcare providers gain access to the world’s largest radiology AI marketplace with more than 300 AI applications from over 100 partners. In addition to this, the CARPL platform also enables its customers to build, test, deploy, and monitor AI across clinical workflows while remaining vendor-neutral and infrastructure-agnostic.

The investment will support continued product innovation, expansion of CARPL’s global partner ecosystem, and commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets. The partnership also reflects a shared focus on advancing digital health innovation through CARPL’s model of building high-skill engineering, product development, and AI capabilities in India for deployment to healthcare providers around the world.

“Our mission is to ensure that clinicians can confidently utilize the absolute best AI technology available for their patients. Over the past few years, we have built…

Full release here, originally announced July 23rd, 2026.


Pearl Health Raises $110 Million to Expand Its AI Platform Helping Providers Deliver Better Outcomes at Lower Cost for Medicare Patients

The Company Reached Profitability in 2025 and is Projected to Generate $500 Million in Gross Healthcare System Savings While Tripling Its Patient Base from 2024 Through the End of 2026

Pearl Health, a healthcare technology company helping manage risk and deliver better care to Medicare patients, today announced a $110 million capital raise, comprised of equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp, Ulysses Capital, and a debt facility led by Trinity Capital. The new capital will expand Pearl’s AI platform, turning clinical intelligence into measurable outcomes, and accelerate its growth across enterprise health system and payer partnerships, its expansion into Medicare Advantage, and new risk offerings.

More than 70 million people today rely on Medicare, with costs exceeding $1 trillion and climbing. Across healthcare, reimbursement is increasingly tied to outcomes rather than utilization, creating powerful incentives for providers to prevent avoidable illness, intervene earlier, and manage patient populations. As healthcare shifts from reactive treatment to preventative care, demand is accelerating for technologies that enable providers to succeed in this new model.

“Pearl was founded on a simple belief: healthcare should reward keeping people healthy, not just treating them when they are sick,” said Michael Kopko, Co-Founder and CEO at Pearl Health. “Unnecessary costs and poor outcomes persist in US healthcare because most providers lack the capabilities to shift to outcomes-based care alone. With this financing, we are investing in accelerated innovation and growth to expand our impact across the healthcare system.”

“Pearl has demonstrated that managing risk across large patient populations across many different settings of care can improve patient outcomes, generate meaningful savings, and support a sustainable business model at scale,” said Vineeta Agarwala, MD, General Partner at Andreessen Horowitz. “Pearl’s ability to enable providers to participate in value-based payment programs successfully – and to do so through technology, rather than clinical workforce expansion – is a testament to both the vision and execution of the Pearl team.”

“We believe Pearl Health is changing how providers participate in value-based care, simplifying the data and daily workflow so they can spend more of their time and attention on their patients,” said Phil Gager, Senior Managing Director, Tech Lending at Trinity Capital…

Full release here, originally announced July 8th, 2026.



Sunday, July 26, 2026

< + > Bonus Features – July 26, 2026 – 92% of healthcare leaders say deep healthcare expertise is critical when evaluating AI vendors, fewer than two-thirds of patients are committed to staying with their provider, plus 34 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT that we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.

News from Capitol Hill

  • ONC released v7 of USCDI, the United States Core Data for Interoperability standard. It includes 30 new data elements, 15 of which are already represented in implementation specifications required in the ONC Health IT Certification Program and are already largely supported by certified health IT.
  • In addition, ONC announced nine Phase 1 winners of its EHIgnite Challenge to “use advanced AI to turn dense [electronic health information] exports into clearer, actionable information for patients, caregivers, and clinicians.” The winners move on to Phase 2, which will conclude in March 2027.

Stats

Partnerships

Products

Implementations

Company News

People

If you have news that you’d like us to consider for a future edition of Healthcare IT Today Bonus Features, please submit them on this page. Please include any relevant links and let us know if news is under embargo. Note that submissions received after the close of business on Thursday may not be included in Bonus Features until the following week.



Saturday, July 25, 2026

< + > Weekly Roundup – July 25, 2026

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.

As U.S. Hospitals Drown in Claims, Canada Misses Clinical Data. Colin Hung caught up with ScoJo Consulting CEO Jodi McMullin, who explained that American hospitals creates a massive volume of codes per chart, so they can bill for specific treatments and avoid payer audits, while Canadian hospitals have no such need to track incidental histories for billing. Read more…

How AI and Automation Are Reshaping RCM. John Lynn chatted with Omega Healthcare CEO Anurag Mehta about leveraging AI to check 100% of submissions and prior authorization requests rather than just a small subset, which can lead to more efficient billing and higher rates of reimbursement. Read more…

Moving HIM From the Back Office to Strategic Leadership. Canadian Health Information Management Association CEO Mahmoud Suleiman talked to Colin about actively deploying HIM experts in high-level oversight roles to protect data architecture – and produce better outcomes. Read more…

How Regulatory Changes and Evolving Payer Requirements Impact RCM Technology Strategy. Amid a complex environment, the Healthcare IT Today community recommended identifying platforms that can evolve, aligning workflows across business units, and advocating for standardization in prior authorization. Read more…

How Clinical, Billing, and Payer System Interoperability Impacts Revenue Cycle Efficiency. The experts at Healthcare IT Today also shared tips for overcoming these challenges such as increasing collaboration, improving data standards, breaking down data silos, and automating repetitive processes. Read more…

New Value in Service Desk Data Collected Through AI. John connected with Dan O’Connor and Chris Durham at HCTec to discuss gaining valuable operational data from every service desk interaction and turning that information into actionable insight. Read more…

Life Sciences Today Podcast: Breaking Clinical Data Chaos. Danny Lieberman talked to Raj Indupuri at eClinical Solutions about treating clinical development like a continuous learning system instead of a sequence of disjointed handoffs. Read more…

Healthcare IT Today Podcast: World Cup of Health IT. John and Colin debate who deserves a yellow card or red card in the industry, along with whether cybersecurity of clinical efficiency wins a close match in the procurement office. Read more…

The IDR Battle Is an Architecture Problem. AI Is How You Build the Fix. Providers win 7 times out of 8 under the No Surprises Act’s independent dispute resolution process, in large part because payers are short-staffed, said Shuo Yang at Daffodil Health. Fortunately, claims communication is well suited to the use of AI. Read more…

What Defending a 49-Pharmacy Network Through War Taught Me About Healthcare Security. Andrii Klepak at CloudCare Pro, and lead infrastructure engineer for a pharmacy network operating in Western Ukraine, provided five disciplines a small practice needs to adopt and five questions to ask every vendor based on his experience. Read more…

Why Ireland Is Emerging as a Hub for SaMD and EU Health Data Innovation. Qurrat Ul Ain at IDA Ireland explained that the country hosts a strong base of global medtech and IT leaders, which positioned Ireland as an incubator for next-generation medical devices, AI systems, and regulated digital health products. Read more…

Beyond Therapy Bots: Evaluating AI at the Front Door of Mental Health Care. Because admissions and referrals in behavioral health are moments when families may be overwhelmed, AI used at this stage of care must be evaluated differently than other tools, according to Dylan Abrams at InStride Health. Read more…

Community Health Centers Need Low-Cost Data Infrastructure to Improve Population Health. Healthcare’s data problems begin at the point of documentation, Dr. Shazia Fathima noted. Ensuring data is pulled consistently, validated before it’s shared, visualized so leaders can understand it, and connected to a clear action plan doesn’t take sophisticated tools. Read more…

This Week’s Health IT Jobs for July 22, 2026: Medical University of South Carolina seeks a Deputy CIO. Read more…

Bonus Features for July 19, 2026: 5 in 6 clinicians use AI without guidance from their employer, 29% of patients’ AI conversations happen outside business hours. Read more…

Funding and M&A Activity:

Thanks for reading and be sure to check out our latest Healthcare IT Today Weekly Roundups.



Friday, July 24, 2026

< + > Breaking Clinical Data Chaos – Life Sciences Today Podcast Episode 71

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Raj Indupuri, Co-Founder and CEO at eClinical Solutions. Why is clinical development still run like a sequence of handoffs instead of a continuous learning system? In this episode, I talk with Indupuri about the industry’s biggest anti-pattern: milestone-based, sequential trials. We discuss clinical data chaos, AI in regulated environments, the real moat behind trusted execution, and how sponsors are starting to treat clinical data as core IP. We also dig into switching costs, CRO channel conflict, and what Indupuri says eClinical will deliver for customers over the next 12 months: faster cycle times, less manual work, and more agile decision-making.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

  • What’s the biggest anti-pattern in the industry?
  • Tell me about your personal journey.
  • How do you create value?
  • How do you capture value?
  • You work with sponsors and CROs – how do you handle channel conflict?
  • What is your moat? What does a greenfield competitor building this today get right that you can’t?
  • What are three things you are going to do for your customers in the next twelve months?

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!



< + > Lyric Acquires Concert | SpinSci Acquires Dialog Health

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.


Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform

Acquisition Reinforces Lyric’s Commitment to Healthcare Decision Intelligence Across the Healthcare Ecosystem

Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, today announced its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions.

The acquisition advances Lyric’s mission to build the most innovative and impactful company in healthcare decision intelligence. By combining Concert’s proprietary capabilities with Lyric42, Lyric’s Healthcare Decision Intelligence Platform, the company extends its ability to serve clients at a time when advanced diagnostics such as genetic testing and the rapid development of new therapies are reshaping healthcare.

Health plans face urgent demands to manage rising costs and keep pace with rapidly evolving clinical evidence. To meet these demands, plans require solutions that bring policy, data, and decision-making together in the systems they and their providers already use. The combination of Concert’s policy intelligence with the Lyric42 platform delivers that solution to Lyric’s clients at a critical moment.

“Healthcare decision intelligence will define the next decade of this industry, and Lyric is built to lead it,” said Halsey Wise, Lyric CEO. “Healthcare is entering a new era where frontier capabilities are propelling precision diagnostics, personalized therapies, specialty medicines, novel treatment modalities, and rapidly evolving clinical evidence. These themes will all redefine patient care. By combining Concert’s evidence-based, precision medicine capabilities with Lyric’s AI-powered Healthcare Decision Intelligence Platform, we offer our clients critical insights and intelligence. On behalf of our health plan clients, we continue to innovate and activate Lyric42 to create the most unique and powerful decision intelligence platform in the marketplace.”

Concert brings to Lyric a proprietary approach for building machine-readable clinical policy, developed over more than a decade of work in precision health payment accuracy.

“Concert was built on the conviction that clinical and administrative policy should be transparent, evidence-based, and computable, delivered into the systems that health plans and providers actually use to make decisions,” said Rob Metcalf, CEO at Concert…

Full release here, originally announced July 15th, 2026.


SpinSci Acquires Dialog Health, the Leader in Patient Communications for Health Systems

Acquisition Adds Enterprise-Scale RCS-Powered Patient Texting to SpinSci’s Generative AI-Powered Patient Access Solution

SpinSci, the agentic AI company for patient access, today announced it has acquired Dialog Health, a patient communication platform trusted by Fortune 500 health systems, health plans, and ambulatory surgery centers. The acquisition expands SpinSci’s AI-powered patient access platform by adding Dialog Health’s proven patient engagement and communication capabilities, creating a more connected healthcare experience. Together, the companies will deliver a seamless patient journey—from proactive engagement and access to care through workflow automation and issue resolution—while accelerating innovation through greater scale, resources, and investment.

Dialog Health brings a proven two-way texting and RCS platform with reach rates of up to 96%, helping healthcare organizations engage patients through automated workflows and communications that support appointment reminders, confirmations, recall, orders, surveys, billing follow-up, and staff engagement, all through seamless integrations with leading healthcare EHRs and systems. That capability complements SpinSci’s existing Voice AI-powered patient access and notification solutions, giving health systems a unified platform for proactive patient engagement across both voice and text.

“From the start, Dialog Health has been singularly focused on helping healthcare organizations connect with their patients through two-way texting, real conversational engagement, and doing it better than anyone in the space,” said Andy Asava, CEO at SpinSci. “Their platform is trusted by some of the largest health systems in the country, and the results they have delivered speak for themselves. We are honored to welcome this talented team to SpinSci.”

Both companies share a defining trait: a singular, multi-decade focus on healthcare. Dialog Health built its platform specifically for the realities of healthcare communication, including HIPAA, TCPA, and CTIA compliance, rather than retrofitting a generic marketing texting tool. This common focus between SpinSci and Dialog Health makes the integration far deeper than a typical acquisition.

“We have spent more than a decade proving that the right message, at the right time, drives patient action, improves experiences, and protects revenue,” said Sean Roy, CEO at Dialog Health…

Full release here, originally announced July 14th, 2026.



< + > The Hidden Risk of Rushed Technology: Patrick Lo on Establishing AI Governance

The healthcare industry is rushing to adopt artificial intelligence tools, but many organizations are moving too fast without proper safegua...